Literature DB >> 2831048

LY146032 treatment of Clostridium difficile colitis in hamsters.

C E Nord1, A Lindmark, I Persson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2831048     DOI： 10.1007/BF02013073

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  3 in total

1.  Susceptibility of Clostridium difficile to LY146032.

Authors:  C E Nord; A Lindmark; I Persson
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

2.  In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; S Willey; E Reiszner; P G Spitzer; G Caputo; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

Review 3.  Aspects on antibacterial treatment of anaerobic infections.

Authors:  F Nordbring; C E Nord
Journal:  Scand J Infect Dis Suppl       Date:  1982
  3 in total
  1 in total

1.  In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerrin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.